| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  MedInsights Reimagining drug repositioning At MedInsights, we are dedicated to bringing optimized therapeutic options for patients suffering from rare diseases. Our internal drug repositioning engine, NexusRx, serves as a cornerstone for our discovery research, employing internal sets of proprietary algorithms to detect unknown and unforeseen relationships between disease-targets-drugs. This opens up preclinical validation opportunities which we perform in close partnerships with our academic collaborators. We envision to perform clinical trials and bring therapeutics from lab to bed side. Crunchbase profile: https://www.crunchbase.com/organization/medinsights-0569 Biotech, Data Science, and Healthcare Type: | 21 | 3 | 6 | 7 |
 |  ElyssaMed SAS ElyssaMed® will develop the first therapeutic treatment for clinical use comprising several antigenic peptides (epitopes) derived from CTPP and selective for non-small-cell lung cancer, combined with an already marketed vaccine adjuvant. This product once administered to lung cancer patients, will amplify the patients' specific immune responses against tumor cells expressing the antigen CTPP and lead to their destruction. Type: | 4 | 4 | 0 | 2 |
 | KALSIOM SAS Targeting calcium signaling to cure auto-immune diseases KALSIOM is a biotech company founded in April 2020 and based in Brest, France, discovering and developing first-in-class therapies to treat auto-immunes disorders (AID) involving B-cell dysfunction with a high medical need. The company is focusing on developing first-in-class monoclonal antibodies modulating calcium-signaling pathways in lymphocytes. Immunology and Therapeutic antibodies Type: | 5 | 3 | 1 | 5 |
 | eVeDrug [Automatic translation follows] eVeDrug calls upon various stakeholders all linked to the field of Pharmacovigilance: professionals from the pharmaceutical industry and scientists who have pooled their know-how, and who draw on their experience acquired both from industrial circles (laboratories and manufacturers) and institutional circles (health authorities from different countries). Above all, eVeDrug wishes to restore trust between patients and their health system by placing the main person concerned (the patient himself) at the center of the health system responsible for protecting him. Thus, eVeDrug distributes the free My eReport application which allows any person (patient, relative, health professional, etc.) who … Type: | 18 | 2 | 10 | 6 |
 | Planktovie Innovation for Aquatic Animal Research Planktovie’s vision is to develop planktonic nutritional solutions meeting the highest standards for the maintenance of your aquatic animal models, and helping to fulfill the 3Rs (Reduce, Refine, Replace the use of animals for scientific purposes) concept (http://www.nc3rs.org.uk/). Aquatic animal models are gaining in importance as alternatives to more conventional models such as rodents. The use of zebrafish is rapidly expanding in both basic and applied research in areas such as clinical research, pharmacology, and drug discovery. The husbandry requirements of zebrafish, and especially their nutritional needs, have a massive impact on both the number … Type: | 11 | 2 | 8 | 4 |
 | BioIntrant [Automatic translation follows] Probiotic Agriculture: Improving Agricultural Productivity Through Plant Health BioIntrant integrates more than thirty years of research at the interface of agronomy, pedology, microbial ecology and bioinformatics, in order to develop biostimulants for modern and responsible agriculture. To do this, BioIntrant integrates the plant into its environment (plant triptych, soil structure, microorganisms) to promote its intrinsic ability to defend itself. It is now possible, thanks to the most advanced technologies and knowledge of the microbial ecology of plants, to restore this natural balance. Biotechnology, Agriculture, Agronomy, Microbiology, Biostimulant, Bioinformatics, and Genomics Type: | 12 | 2 | 11 | 4 |
 | Dyameo [Automatic translation follows] Dyameo is a research & development company in the field of medical devices that designs probes to help diagnose cancer cells in vivo. This medical device allows to answer the question: "Are these cells cancerous?", and this in a simple, clear and instantaneous way. This breakthrough solution proposes to discriminate cancer cells at an early stage, during endoscopic examinations. Medical devices, MedTech, and Aid to in-vivo cancer diagnosis Type: | 2 | 2 | 0 | 9 |
 | Prostperia Innovative cancer screening tests PROSTPERIA aims at researching and developing new "in silico" screening tests for several cancers. At PROSTPERIA we want to make personalized medicine a reality by steering clear of the "one size fits all" model. Our first test, PROSTia, targets the early detection of prostate cancer. Type: | 3 | 1 | 1 | 4 |
 |  BILHI Genetics The genetic platform to EXPLORE, PREDICT and CURE fibrotic diseases We are a team of GENOMIC EXPLORERS dedicated to cure fibrosis. We work hand in hand with populations under strong natural selection pressure (e.g. Amerindians from Brazil, Allurs, Bantous from Uganda, Hans from Wuhan...) to identify GENETIC VARIANTS of susceptibility or resistance to fibrotic diseases. To explore the mechanisms of fibrosis in new depth, we rely on a unique genomic strategy based on medical genetic expertise in fibrosis, local networks of fields experts and state-of-the-art AI. In cooperation with local institutions & KOLs, our experts have analyzed tens of thousands … Type: | 1 | 1 | 1 | 5 |
 | PK MED Tailor-designed drug implants for local treatments. Founded by Truffle Capital. PK MED is a French innovative biotech company, privately owned and established in 2019 with the support of Truffle Capital, a European Venture Capital firm specializing in Life sciences. PK MED was created around a small team of passionate and experienced experts in pharmaceutical and medical sciences, drug delivery and biomaterials design. PK MED specializes in the innovative development of custom-designed, injectable, and biodegradable micro-implants. Our expertise spans across critical healthcare domains, focusing on drug delivery systems for rheumatology and enhancing cell-homing techniques to improve bone marrow transplantation outcomes. The … Type: | 5 | 1 | 4 | 10 |
 | Cell&Soft Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish Type: | 4 | 3 | 1 | 5 |
 |  AELIS FARMA A clinical stage biotech company opening a new frontier in pharmacology Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials … Type: | 6 | 2 | 4 | 31 |
 | Inotrem Control innate immunity Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock. Founded in 2013, with offices in Paris and a technology center in Nancy (France), the company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Leveraging its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, nangibotide, with applications in a number of therapeutic indications such as septic shock or myocardial infarction. Next to acute inflammatory syndromes, Inotrem is also developing a program targeting chronic inflammatory diseases. Type: | 7 | 6 | 1 | 33 |
 | BioMathematica Unlocking biology using mathematics At Biomathematica, we believe mathematics has the power to revolutionize biology. We have developed a Systems Biology approach to characterize, predict, engineer, control and optimize simple and complex microbial communities. We use this technology for: -The development of probiotics / prebiotics / synbiotics and live biotherapeutics targeting the human microbiome. -The engineering of bacterial strains or consortia targeting the animal, environmental and artificial microbiome(s). -The design of new metabolic pathways involving several bacterial or unicellular strains. -Other bioinformatics services such as Shotgun Metagenomic data analysis, Strain level resolution for bacteria, virus, fungi, protists (WGS), Gene characterization … Type: | 11 | 2 | 4 | 2 |
 | Woodlight [Automatic translation follows] Let's cultivate the light of tomorrow! Since its foundation in January 2016, Woodlight has been a research and development startup for new biotechnologies. Its goal is to make cities greener by addressing their problems of pollution, lack of greenery and high energy consumption. To meet the growing needs for sustainable lighting and energy savings in cities, Woodlight proposes to develop a process to make plants bioluminescent. These plants can be used as mood lamps for interior decoration. We can then imagine an ivy, a ficus or even a luminescent orchid. Beyond these uses, these plants could be … Type: | 35 | 4 | 34 | 6 |
 | Rhenovia Pharma RHENOVIA Pharma is a French biotech company founded in 2007 by an international team comprising executives of the big pharmaceutical industry and world experts in the fields of neurosciences and modeling of the nervous system. In less than 5 years, Rhenovia became a biosimulation world leader in CNS. Its worldwide unique modeling technology makes it possible to reproduce on computers the cellular and molecular mechanisms of the brain and the neuronal transmission. Rhenovia uses its technology to create computational models that simulate the condition of healthy persons or affected by pathologies of the nervous system (Alzheimer, Parkinson, epilepsy, schizophrenia, depression). … Type: | 0 | 0 | 0 | 3 |
 | Amylgen Amylgen is a CRO proposing innovative in vivo models of ageing, psychiatric and neurodegenerative pathologies for the development of new medicines or nutraceuticals. Amylgen is at your service to provide quick POC for your product as a food supplement for brain health and helps you to substantiate the efficacy of your product by preclinical studies in rodent models Amylgen brings you preclinical scientific data for your product on Brain aging preservation Memory enhancement Antidepressant /anti anxiety effect Protection against Alzheimer’s disease Amylgen has access to regulatory and clinical partners to aid in the preparation of health claims for EFSA or … Type: | 3 | 2 | 0 | 1 |
 | Seenel Imaging Seenel Imaging is dedicated to functional Neuroimaging technology. We launched in 2019 a breakthrough research device combining EEG & fNIRS further to 10 years of Academic research. Medelopt® is a wearable High Resolution NIRS/EEG device with unique features on the market. NIRS, EEG, Brain Imaging, Functional NIRS, Cognitive Research, Optical Imaging, Innovation, and Neuroscience Type: | 2 | 2 | 0 | 8 |
 | ScreenCell Isolating CTCs has never been so simple. ScreenCell was set-up with the belief that just enumerating Circulating Tumor Cells (CTCs) without easily characterizing them was not enough to allow the early detection of a disease and to potentially follow-up the cancer progression. So it designed and produced a simple but revolutionary technology allowing the fast and effective isolation of CTCs for a better cellular and molecular characterization, which is essential in cancer monitoring. This technology also contributes to the development of a new non-invasive approach to prenatal diagnosis. Screencell is dedicated to create technologies allowing CTC to become potential end … Type: | 2 | 0 | 2 | 18 |
 | CST - Crime Science Technology Crime Science Technology (CST) develops innovative solutions for identifying persons and securing of documents and products. These solutions are based on innovations developed with the CNRS (French National Center for Scientific Research) and the Ecole Normale Supérieure de Cachan. In the forensic field, our expertise also relies on numerous synergies with public institutions such as the French Forensic Medicine Institute and the INPS (National Institute for Forensic Science). Moreover, it is supported by ongoing exchanges with Technical and Scientific Polices abroad. CST has developed and markets since 2013, the LUMICYANO : the first one step fluorescent cyanoacrylate used for development … Type: | 38 | 3 | 38 | 13 |
 | Mablink Bioscience Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D Type: | 15 | 9 | 10 | 35 |
 | Rising up Paris [Automatic translation follows] Identify, enrich, map and certify your students' soft skills! Rising Up has created THE LAB. the only online soft skills platform capable of assessing, enriching, mapping and certifying soft skills. After more than 7 years of R&D with international experts, Rising Up received in 2023 the Deeptech certification of the European Innovation Council (IEC) judging its technology as a disruptive innovation. More than 3000 students love our solutions. Learning, Digital, formpro, softskills, Neurosciences, Devpro, Training, Telework, and communication Type: | 17 | 3 | 14 | 5 |
 | C4Hydro Expert in microorganism detection & enumeration in the environment C4Hydro is a biotechnology company based out of GRAND LUMINY TECHNOPOLE ZONE LUMINY 163 AVENUE DE LUMINY, MARSEILLE CEDEX 09, France. Biotechnologies, Bactériologie, Légionelle, Legionella pneumophila, Environnement, and Microorganismes Type: | 5 | 3 | 2 | 3 |
 | MoreHisto Advancing Biology Research and Digital Pathology MoreHisto is a start-up developing innovative AI-powered biological image analysis software for research and clinical laboratories. Our vision is to empower the health sector by integrating life sciences with technology to secure a sustainable healthcare for living beings. Our mission is to provide biology researchers and clinical specialists with software solutions that assists them in achieving high throughput image analysis. Artificial Intelligence, Image Processing, Biology, Microscopy, Oncology, Clinical Diagnosis, Image Analysis, Software Solutions, Digital Pathology, Pathology, and Research Type: | 11 | 9 | 1 | 8 |
 | MEERSENS Environmental intelligence for smart decisions. Mitigate environmental risks & positively contribute to health/wellbeing Meersens - certified #GreenTech & #DeepTech - is a positively impactful company in the field of environmental health (☁️ air, 💧water, 📣 noise, 🌻 pollen, 🔥 fire, 🌦️ weather, ☀️UV...). Our mission: to build a sustainable future by mitigating environmental risks and promoting the well-being of all stakeholders - by offering personalized environmental monitoring and prevention. Thanks to our cutting-edge tools (SaaS, API, IoT, App), you benefit from 360°, real-time, historical, and predictive information on a multitude of pollutants, for any location. This high precision data enables … Type: | 73 | 16 | 69 | 12 |
 | Suricog SuriCog was founded in mid-2013 by Marc Massonneau, serial entrepreneur in medical devices & services, and some other passionate people, to develop new generation of gaze-based diagnostic tools in order to improve patient pathways in neurology and psychiatry. In 2016, we acquired a company which developed a 10M€ program for best-in-class eye-movement acquisition and analysis solutions in several key neurological diseases Drawing from over a quasi-decade of eye studies, algorithm development, optoelectronics design, high-end software, and clinical trials and applications, we have advanced our technology for integration in a data-driven complete solution, as the fundamental for medical oriented eye-tracking. The … Type: | 2 | 4 | 0 | 18 |
 | Perha Pharmaceuticals From Sea to Pharmacy Perha Pharmaceuticals is a biotech company identifying, optimizing and characterizing innovative, low molecular weight kinase inhibitors and developing them up to proof-of-concept in man. Perha Pharma focuses its research on two main diseases: cognitive disorders associated with Down syndrome (DS) and Alzheimer’s disease (AD), and hearing loss (HL) induced by ototoxic products. The first proof-of-concept in man should be achieved in both pathologies through niche indications: cognitive deficits in DS and hearing loss induced by cis-platin or aminoglycoside antibiotics. Perha Pharma was co-founded in April 2019 by Dr Laurent MEIJER, Chairman & CSO, former distinguished Director … Type: | 5 | 5 | 0 | 12 |
 | BioMAdvanced Diagnostics Disrupting the Field of Biomarkers BioMAdvanced Diagnostics is a MedTech start-up based in Nantes, spinoff from the CR2TI (Centre de Recherche Translationnelle en Transplantation et Immunologie, UMR 1064, INSERM – Nantes University) and from the University Hospital (CHU) of Nantes. BioMAdvanced Diagnostics brings a real disruption in the field of Biomarkers based on 20 years of translational research. Its main goal is to enable a really personalized medicine which will greatly improve outcomes for the patient by providing unprecedented tools to clinicians. More specifically, great attention is being placed towards diminishing risks for patients through minimal invasive solutions which will … | 10 | 6 | 7 | 12 |
 | CTIBiotech Visionary science. CTIBiotech, models for your research. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come … Type: | 19 | 2 | 15 | 22 |
 | Ecrins Therapeutics Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical proof of concept. In addition to the drug discovery, Ecrins Therapeutics provides a range of products and services for the benefit of our customers in biotechnology companies, universities, public research institutions and in the pharmaceutical industry. The mission of the commercial division of Ecrins Therapeutics is to help medical chemists and drug hunters to discover, characterize and advance their lead compounds through the drug development process. Visit http://ecrins-therapeutics-services.com/ for more information. Our research and production … Type: | 3 | 0 | 3 | 1 |
 | Pomega Laboratories New Natural & Ethical Anti Inflammatory Pharmaceutical Products Natural Products with Proven Health Claims For PETS. Pomega develops a novel, safe, ethical and non-toxic therapy that retards disease progression by inhibiting cartilage breakdown at an earlier stage. Product is developed by skilled pharmacist under drug standards frame First product coming out the pipeline is Ω-344 Product , a patented fruit extract with strong anti inflammatory properties osteoarthritis , anti inflammatory, fruit extract, inflammation, arthritis, biotech, NSAIDs, pain, animal, dogs, pets, wellness, healthcare, petfood, and cats Type: | 1 | 1 | 0 | N/A |
 | BELAB R&D : Développement de dispositifs d’analyse physiologiques connectés pour la mesure de la sudation en temps réel We are a Start Up of innovators, caring people and believers in a u cause. Within the biotech area, we create state of the art and patented solutions to address an important concern : the measurement and monitoring of crucial physiologic indicators of sweat. The Be-Lab Team, Live better, together. | 4 | 3 | 2 | 11 |
 | Sirius NeoSight [Automatic translation follows] New view for cancer therapeutics Sirius NeoSight is an innovative technological breakthrough company whose ambition is to become a key player in the detection of subclinical neo-cancers, relapses and therapeutic monitoring of patients, thus offering doctors a new perspective on the therapeutic efficacy implemented. Sirius NeoSight uses a patented breakthrough technology from a consortium of academic laboratories that are experts in the field. Type: | 17 | 6 | 6 | 4 |
 | ALPHANOSOS OneHealth/AI DeepTech discovering patentable mixes of natural ingredients preserving health and optimizing bioprecesses Alphanosos, a Green One-Health DeepTech company, uses its own Artificial Intelligence algorithms to discover, develop and market active ingredients and products based on blends of extracts from non-pharmaceutical ingredients, in particular edible plants. These active mixtures, some of which are already patented in 15 countries for their antimicrobial activities, are intended for the animal hygiene, dermocosmetics, food preservation and cosmetics sectors, bioprocess optimization and in the longer term, for functional foods and disease treatments. The company began its Research and Development (R&D) activities in mid-2015 and is … Type: | 4 | 3 | 1 | 4 |
 | Micropep Technologies Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins. Type: | 19 | 11 | 6 | 57 |
 | Nahibu MICROBIOME PROFILING Nahibu is a leading global microbiome company offering NGS analysis, advanced analytics, and end-to-end research support. Our platform provides the most extensive metagenome and metadata catalog for data mining and microbiome association discovery. Type: | 15 | 4 | 1 | 10 |
 | AlgoTx AlgoTx develops novel therapeutic solutions for complex pain AlgoTx is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain. Non-opioid, locally acting ATX01 is designed to treat the pain of Chemotherapy-Induced Peripheral Neuropathy, a common and painful side-effect of cancer treatments. It targets the signaling pathways involved in the regulation of pain by selectively inhibiting specific nociceptive sodium channel receptors. FDA granted ATX01 Fast-Track designation. The ACT study is an international Phase II randomized, placebo-controlled trial involving over 270 patients ; The results will be available in early 2025 and the company is making … Type: | 4 | 3 | 2 | 12 |
 | xRapid Group Pushing the boundaries of Artificial Intelligence in diagnostics Environmental Services - Biotechnologie Founded in 2015 by Jean Viry-Babel and Prof. David Mendels, xRapid Group was created with the hope of applying the evolving technologies of artificial intelligence (AI) and computer vision to previously unexplored fields with the hopes of improving the lives of people the world over. The first application of Prof. Mendels knowledge was to tackle the issue of diagnosing malaria in remote areas where the demand for skilled analysts exceeded the supply of resources, both human and monetary. It was during the research and development of this application … Type: | 12 | 5 | 9 | 1 |
 | HEPHAISTOS-Pharma [Automatic translation follows] Developing the weapons that we need to defeat cancer. HEPHAISTOS-Pharma is a biotechnology startup developing anti-tumor immunotherapies to revolutionize cancer treatments by increasing the effectiveness of monoclonal antibodies and allowing the treatment of incurable tumors. Oncology, immunotherapy, and cancer | 23 | 11 | 6 | 11 |
 | Loop Dee Science Tests you can trust ! Making molecular biology faster and more accessible! Founded in 2017 and based in Caen in Normandy, Loop Dee Science is a DNA expert start-up that makes molecular biology diagnostics more accessible to as many users as possible. Our expertise is based on the use of amplification technology and the creation of tools to automate these tests. We develop and manufacture rapid, reliable and simple genetic analysis kits for use in the field to detect pathogen DNA and RNA. Biologie moléculaire, Kits d'analyses terrain, Kits vétérinaire, Recherche et développement, and PCR Type: | 8 | 3 | 5 | 12 |
 | IOME BIO Harnessing unique, proprietary microbiome insights to unlock the efficacy of immuno-oncology Cancer continues to be a leading cause of disability and early mortality worldwide. Immune checkpoint blockade with PD/L-1 therapies such as Keytruda and Opdivo can induce complete and durable clinical responses in multiple tumors, a breakthrough in cancer treatment over the last decade. However, only around 20% of patients respond and many trials have failed Many R&D programs in multiple companies are attempting to improve the clinical efficacy of PD/L-1 therapies, but no solution is yet approved. Most of these approaches target T-cells or the tumour microenvironment. Patients with … Type: | 5 | 2 | 4 | 4 |
 | PEPTINOV Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-François Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinov’s strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinov’s high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinov’s value proposition is built on its unique capability to develop anti-self proteins … Type: | 2 | 2 | 0 | 16 |
 | Kaer Labs In vivo small and large animal near infrared fluorescence imaging Kaer Labs develops and sells innovative in vivo fluorescence imaging solutions for researchers. Our systems are used by academic and private laboratories working on medical or pharmaceutical research In vivo near infrared fluorescence, Molecular Imaging, and Small and large animal open fluorescence Type: | 4 | 3 | 0 | 6 |
 | ANTABIO Developing Tomorrow's Antibacterials Antabio is a privately-held clinical-stage biopharmaceutical company developing novel and highly differentiated antibacterial treatments for drug-resistant infections due to CDC and WHO critical priority pathogens. Please visit www.antabio.com and follow us on Twitter @antabio Antibacterial drug discovery, Drug development, and Antibiotic Adjuvant Type: | 21 | 8 | 13 | 21 |
 | Mapatho [Automatic translation follows] The collaborative toolbox for my pathology Mapatho is the collaborative toolbox for my pathology So that each patient has the freedom to choose their caregivers and equal access to experts in their chronic disease by counting on the fraternity of each. With Mapatho, SHARING (one's experience, one's findings) means HELPING (other patients). This is why we are getting more and more involved in helping the 20 million French people with a chronic disease find the resources and information to better live with their disease on a daily basis. On www.mapatho.com, everyone can find all the latest news … Type: | 24 | 2 | 26 | 8 |
 | Occentis Occentis is a drug discovery and development company, focusing on Autism, Alcohol and Opioid addiction and Pain. Occentis is a drug discovery and development company, focusing on mental health, with a groundbreaking approach backed by over two decades of extensive research conducted at the renowned French National Center for Scientific Research (CNRS) under the guidance of Professor Marcel Hibert, a distinguished figure in medicinal chemistry. Our mission is to revolutionise the treatment landscape for neuropsychiatric and neurobehavioral conditions, addressing significant unmet needs in therapeutic areas such as Autism, Alcohol and Opioid addiction, Pain and other conditions. In close collaboration with … Type: | 3 | 2 | 0 | N/A |
 | PKvitality Changing the lives of diabetes patients with K’Watch, the discreet and painless Continuous Glucose Monitoring smartwatch PKvitality is an advanced bio-wearable company which develop K’Track, a line of next generation trackers with the ability to analyze key physiological markers by simply testing the skin rather than analyzing blood samples. The groundbreaking technology brings new capabilities to the health and fitness wearable market. PKvitality is initially launching a glucose monitor, K’Track Glucose, to serve diabetics as well as a lactate monitor, K’Track Athlete,for sports professionals. Availability will follow regulatory clearance. Type: | 12 | 6 | 7 | 10 |
 | CYTOO CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism. High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, and muscle health Type: | 2 | 1 | 0 | 35 |
 | 4mg TRANSPARENCY [Automatic translation follows] Manage your core business, we manage its Transparency! Manage your core business, we manage its Transparency! 4mgTRANSPARENCY works with the Health Industry (pharmaceuticals, medical devices, medical visit providers, medical information delegates, Health events, PSAD) and Health Professionals by offering a personalized management solution, internal or outsourced, of regulatory functions and LEA (ex DMOS) from A to Z thanks to comprehensive support on the subject: - Audit of internal LEA (ex DMOS) and Transparency management processes - Management of administrative files (IDAHE, EPS) - Implementation of 4TRANSPARENCY, the innovative, efficient, profitable and agile digital platform that simplifies Transparency … Type: | 40 | 0 | 39 | 3 |
 | SYNTHELIS Cell-free systems expert ! The futures of protein ! Best chance for your protein projects ! A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. … Type: | 16 | 5 | 12 | 9 |
 | kyron.bio Next generation bioproduction platform Kyron.bio is revolutionising the way we make our therapeutic drugs. Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective. Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved by the pharmaceutical … Type: | 11 | 3 | 9 | 6 |
 | Itris Automation Itris Automation, a Schneider Electric company, is a software engineering company that provides development tools for the verification, conversion and documentation of PLC codes to complement the programming tools of international PLC vendors. As PLC programs become bigger and more complex, the need to ensure their quality and maintain them at the lowest possible cost has never been greater. Thanks to their advanced technologies, Itris Automation supports their customers, whether project managers, developers, quality managers, or industry experts, in improving their development processes and therefore in delivering higher quality programs in shorter timeframes. With a team that is known for … Type: | 1 | 0 | 1 | 6 |
 | Vidium Solutions Data analysis and in silico modelization solutions for genetic research and personalized medicine Expert in systems biology, VIDIUM brings data analysis and in silico modelization solutions for genetic research. We unlock the power of single-cell analysis to characterize and master the complexity of cell fate dynamics: "As Google did for urban networks, we built our navigation map in cellular genetic networks!" Guided by knowledge-driven approaches, we create highly representative digital twins from single-cell data, to make accurate predictions. These in silico avatars of genetic networks allows us to "find our way" through the billions of possible interactions between our 20,000 … Type: | 5 | 0 | 4 | 8 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 27 | 8 | 22 | 14 |
 | NEURO-SYS CNS/PNS - In vitro - In vivo - Drug Development Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s … Type: | 0 | 0 | 0 | 34 |
 | MRGM : Maladies Rares Génétique et métabolisme La recherche du MRGM vise à décrypter les mécanismes moléculaires à l'origine de la physiopathologie des maladies rares. MRGM aims to decipher the molecular mechanisms laying at the root of the physiopathology of rare diseases and make our findings worth for patients | 1 | 0 | 0 | 3 |
 | Domain Therapeutics #biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and … Type: | 20 | 6 | 17 | 86 |
 | ID SOLUTIONS ID SOLUTIONS offers comprehensive Molecular Typing Assays using DigitalPCR for Oncology Diagnostics Our mission To provide innovative, reliable and standardized tools for oncology diagnostic. Research on circulating DNA from liquid biopsy, tumor DNA from solid biopsies. Our team is of molecular biology specialists with more than 20 years of expertise in nucleic acid extraction, molecular biology and oncology. Our proposals To offer a complete molecular typing solution, standardized operating procedures and custom development to improve diagnosis in oncology. biologie moléculaire, diagnostic oncologique, ADN circulant, biopsie liquide, PCR, Digital PCR, Multiplexing, Covid-19, and SARS-CoV-2 | 6 | 2 | 4 | 86 |
 | Cearitis [Automatic translation follows] Biocontrol and innovation for the protection of your crops. CEARITIS supports you in the protection of your tree crops thanks to biocontrol and agroecology. 🌿 We offer a Biocontrol system for protection against tree pests. Inspired by what already exists in nature, this solution mimics the interactions between the tree and the pest. Composed of an attractant and a repellent, this autonomous system protects up to 90% of your crops. 🌿 We offer an agroecology support service that allows sustainable management of natural resources for autonomy and sustainability of orchards. By working on the design of the … Type: | 29 | 13 | 20 | 19 |
 | ALCEDIAG Biomarker-based diagnostics for Mental Health Biomarker-based diagnostics for Mental Health ALCEDIAG is a personalized medicine company specializing in the development of biological signatures aimed to serve as the basis of diagnostics tools, with a primary focus on mental health. These biomarkers are based on the analysis of RNA editing, an epigenetic mechanism altering the nature and conformation of RNA. RNA editing may lead to the production of altered forms of proteins or modify the regulation of gene expression. RNA editing can be modified in the case of certain diseases, or as a consequence of a medical treatment. ALCEDIAG blood biomarkers … Type: | 17 | 1 | 16 | 14 |
 | LIFE MEDICAL CONTROL [Automatic translation follows] Stroke is not inevitable. o Research, Medical, and Primary prevention of stroke risks Type: | 3 | 0 | 3 | 3 |
 | Advesya Transforming cancer and autoimmune treatments with unique IL-1RAP targeting approaches Advesya is a pioneering and transformative biotechnology company developing therapies for difficult-to-treat cancers. Haematology & Oncology, Antibody Drug Conjugate, Cell Therapy, and Autoimmune Type: | 7 | 2 | 1 | 24 |
 | HypnoVR Treating pain and anxiety differently. HypnoVR is a medical device combining the benefits of medical hypnosis with virtual reality. Designed by two anesthesiologists and hypnotists with more than 15 years of experience, HypnoVR has demonstrated its effectiveness in the treatment of pain and anxiety through 15 clinical studies (postoperative length of stay divided by 3.57 and 45% reduction in morphine consumption). HypnoVR is a simple and quick tool for health professionals, especially those specialized in anesthesia, surgery and dental surgery. It complies with the hygiene standards of health institutions and medical practices: HypnoVR adapts to your care organization with a … Type: | 36 | 18 | 22 | 35 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … Tags: FrenchTech120 Type: | 17 | 11 | 6 | 126 |
 | Biomanda [Automatic translation follows] Created in September 2013 by Julien Gardès, Biomanda offers bioinformatics services specialized in the detection and studies of microbial biodiversity. Develop a PCR (Polymerase Chain Reaction) or qPCR detection solution to target any microorganism or virus. Improve your PCR detection solutions to have maximum specificity and sensitivity. Benefit from new generation microbial biodiversity studies (metagenomics) to know with great precision the effect of a product on the microbial flora of an environment or living tissue. We also analyze all types of biology data with the possibility of carrying out data-mining steps (i.e. searching for additional information on … Type: | 0 | 0 | 0 | 1 |
 | StarkAge Therapeutics Immunotherapy against senescence StarkAge Therapeutics is a privately-held biotechnology start-up, whose ambition is to delay or halt disease progression and improve quality of life of patients with age-related diseases, associated with senescent cells accumulation. It builds on its unique disease-specific exosomal / EV technology while harnessing immunotherapy approach, to address very large senescence unmet medical needs. Type: | 2 | 2 | 0 | 9 |
 | Laboratoire PediAct [Automatic translation follows] A new look at the health of the whole family. By distributing cutting-edge and carefully selected family health products, the PediAct laboratory positions itself as a key player in the health and well-being of the whole family. | 0 | 0 | 0 | 23 |
 | ORPHELIA Pharma Children with rare diseases deserve therapeutic answers ORPHELIA Pharma is a French pharmaceutical company based in Paris and Lyon that develops and markets medicines for the treatment of pediatric orphan diseases. ORPHELIA Pharma‘s mission is to provide patients with essential products in the fields of epilepsy and pediatric oncology, with formulations adapted to the pediatric population. With one drug approved in the European Union and one product in late-stage clinical development, ORPHELIA Pharma has recently established regional agreements in the European Union, the USA and China and conducts research projects through academic and industrial partnerships. Neurology, Pediatry, Orphan drug, and … Type: | 1 | 1 | 0 | 10 |
 | NETRIS Pharma Our collaborators and partners are driven by a desire to contribute to the development of new ways of fighting cancer. The therapies developed by NETRIS Pharma are based on cellular mechanisms identified by a world-renowned research group. Located in Léon Bérard Cancer Center (Lyon, France), NETRIS Pharma is a unique model of a biotechnology company integrated within a comprehensive cancer center. Type: | 1 | 1 | 0 | 19 |
 | MedActiv MedActiv is a global leader in the development of transport and storage solutions for sensitive medication. Our products are designed to give users the freedom to travel knowing that their medication is kept at exactly the right temperature. As the chosen partner of major pharmaceutical companies worldwide, MedActiv is constantly pushing back the boundaries of this industry. The MedActiv solutions are specially designed to bring added value to the medications they are made for. Strategically located in France, UK, USA, Australia and Taiwan, we have the reputation of always anticipating the needs of our customers with an approach that is … Type: | 7 | 3 | 3 | 6 |
 | BIOMNIGENE Molecular biology thought for your needs Biomnigene, a bioanalysis service company, helps prevent potential diseases and to authenticate, trace, secure, validate products and their effects through genetic analysis. Thanks to our expertise, we offer you integrated services for environmental, industrial (pharmaceutical, agro-food, cosmetic) or medical issues such as: - Analysis of the intestinal, skin, vaginal, pulmonary and soil microbiome (16S/ITS metagenomic, shotgun metagenomic, transcriptomic, WGS...). - Identification, quantification and authentication, monitoring of species in a pure sample and in a mixture (microorganisms, viruses, bacteria, meat, fish). - Genotyping - Antibody sequencing and safeguarding of hybridoma lines of special interest; - … Type: | 3 | 3 | 2 | 7 |
 | Jalon Therapeutics Jalon Therapeutics aims to develop innovative therapies that inactivate yet untargeted vital tumor signaling pathways. Jalon Therapeutics aims to develop innovative therapies that inactivate yet untargeted vital tumor signaling pathways. Our mission is to develop medicines that will transform the lives of people fighting cancer. For that purpose, we leverage our deep understanding of stress-related protein-protein interaction networks that sustain the malignant phenotype while not being necessary for normal cells. This mechanism, defined as “non-oncogene addiction” (NOA), offers potential novel, safer and more effective therapeutic strategies. Jalon Therapeutics is rooted in pioneering fundamental research and clinical investigations from INSERM laboratories … Type: | 1 | 1 | 0 | 3 |
 | 4Moving Biotech Restoring mobility for a better quality of life 4Moving Biotech is a clinical-stage biopharmaceutical company founded in 2020. We are committed to develop first-in-class breakthrough therapies for the millions of patients suffering from osteoarthritis (OA) in the world. 4Moving Biotech is a subsidiary of 4P-Pharma, an innovation accelerator biotech company. Osteoarthritis, DMOAD, Research and Development, and Biotechnology | 4 | 3 | 0 | 3 |
 | Okay Doc Institute & Phd Career Okay Doc links business with research Cabinet of high-level advice, Okay Doc offers organizations (CAC40, SMEs, startups, communities, institutions) a privileged contact with researchers to answer the transformation issues (technological, economic, social, environmental, legal, etc.) . Recherche, Innovation, Numérique, Transformation digitale, Données, Universités, Docteurs, Conseil, Consultant, Travail , Avenir, Speaker, Conférence, CIR, RGDP, Neurosciences, Intelligence artificielle, Sciences, Humanités Numériques, Expertise, Cybersécurité, Droit, Prospective, Environnement, Robot, IA, Intelligence stratégique, Doctorat, blockchain, deep learning, machine learning, Future Of Work, recrutement, and sourcing Type: | 28 | 0 | 30 | 29 |
 | MonolixSuite MonolixSuite - a software of Simulations Plus MonolixSuite - built for Model Informed Drug Development computing. It's fast, easy-to-use, and powerful suite of applications for pharmacometrics analysis, modeling, and simulation. Fully interoperable and covering a complete modeling and simulation workflow from data visualization and non-compartmental analysis to population modeling & simulations. Intuitive, effective, and offering the most advanced calculation capabilities. Statistics, Pharmacometrics, Modelling and Simulation, Business software, Clinical trials, PKPD, and Non-compartmental analysis Type: | 1 | 1 | 0 | 17 |
 | Priothera SAS Adding Quality Years of Life We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Type: | 12 | 2 | 2 | 21 |
 | PEAK LIFECYCLES HR - Europe & the US Beyond the people you want, get the people you need PEAK LIFECYCLES HR is an international Executive Search and Talent Management company dedicated to Global "Care environment" markets and their stakeholders. Placing the analysis of the business life cycle, and that of products, skills, and projects at the heart of its activity, Peak Lifecycles' unique, innovative expertise is founded on its anticipation of market requirements. OUR OFFERS: Executive Search, Talent Management, Organizational audit, Executive Coaching We also developed an offer dedicated to Startups and their lifecycles. Executive Search, Talent Management, Life Sciences, Market Access, Medical, Business Operation, Digital , Food, … Type: | 25 | 0 | 23 | 12 |
 | Cure51 We want every patient to become a Cancer Survivor. Cure 51 is a TechBio aiming at creating the first ever worldwide database of Cancer Survivors. The company was co-created with leading oncology centres and has already identified more than 1500 survivors in 42 countries across all continents. The company has developed its own data collection and discovery platform as well as a dedicated Central Lab to proceed to a multiomic sequencing of the survivors’ samples. Through this approach, Cure51 will identify robust therapeutic targets, validated by its scientific community, in order to develop novel drugs to cure Cancer. The focus … Type: | 6 | 4 | 2 | 29 |
 | Epigene Labs augmented intelligence for precision oncology research and drug development Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company's mCUBE platform accelerates data-driven drug discovery, biomarker identification, and patient selection -- to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies. Type: | 10 | 4 | 7 | 33 |
 | COCONT [Automatic translation follows] Fast and unique turnkey plant production Company specializing in the development and production of fermented or non-fermented plant alternatives with high nutritional value. | 5 | 3 | 0 | 4 |
 | StromaCare Stromacare is a pioneer in tumoral stroma immuno-modulation and develops a therapeutic mAb for the treatment of cancers StromaCare is opening a new therapeutic avenue by targeting the tumoral Stroma, which is known to play a key role in several solid cancers, with the objective to be essential in the numerous anticancer protocols of treatment. Stromacare won the Beatrice Denys Foundation 2021 Prize (Foundation for Medical Research). The company is located in Lyon, France. oncology and monoclonal antibody Type: | 4 | 3 | 2 | 16 |
 | Neolys Diagnostics En cancérologie, la médecine personnalisée n’est plus une option. Neolys was born out of a common interest between industry and radiobiology researchers from Lyon, France to meet a particular need: predicting radiosensitivity reactions after radiotherapy for each patient, taking into account individual specificities. Neolys thus developed a reliable technology based on predictive tests, allowing for patient-specific treatments. Our solutions both optimize radiotherapy treatments efficiency and toxicity prevention. Neolys Diagnostics joined ALARA Group in late 2019. Radiation Oncology, Radiosensitivity, Precision Medicine, Médecine personnalisée, Radiosensibilité, and Radiothérapie Type: | 13 | 6 | 6 | 7 |
 | Smart Immune Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T … Type: | 24 | 12 | 14 | 36 |
 | Microlight3D The world's highest resolution 3D-printers for all your micro/nano applications The world's highest resolution (up to 0,1 micron) 3D-printers for all your micro/nano applications. Microlight3D is a specialty manufacturer of ultra high-resolution 3D-printers for industrial and scientific applications. It enables customers with new development needs to produce the most demanding precision micro parts with the smoothest surfaces. The company’s two-photon polymerization technology, which includes proprietary software tuned for increasingly faster direct laser writing speeds with sub-micron resolution, is compatible with the widest range of polymers and biological materials. Sold worldwide, Microlight3D’s microprinting machines produce ready-to-deploy 3D structures in any geometric … Type: | 19 | 7 | 7 | 20 |
 | Nosopharm Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus. Anti-Infectives, Drug Discovery, Antibiotics, and Microbiology Type: | 13 | 11 | 3 | 4 |
 | Arbiom Excellence in protein Arbiom is committed to feeding the world in a sustainable and healthy way. We are mastering the feedstock flexibility, to create the next generation of fermentation products and technologies. We are able to deliver high-quality and sustainable protein ingredients by tapping into nature-based solutions. Arbiom has created two protein-rich ingredients: SylPro for feed with high protein content, excellent digestibility and outstanding palatability suitable for petfood and feed nutrition; Yusto for food which bring quality, taste and well-being to nourrish people sustainably through meat and dairy analogs and specialized nutrition. Arbiom is now focusing on its industrial deployment, … Type: | 16 | 6 | 10 | 23 |
 | NEURON EXPERTS Neuron Experts is a Contract Research Organization (CRO) specialized in the study of neuro-active compounds. The company uses its own tests based on primary neuronal cell cultures modeling neurodegenerative diseases. With 120m2 of independent laboratory into the North Faculty of Medicine of Marseille in France, Neuron Experts is benefiting from numerous facilities and massively invested in high-tech equipment to provide the best service to clients. Type: | 1 | 1 | 0 | 9 |
 | BioC3 Synthetic Biology BioC3 is a French biotech startup that has created an innovative biocatalysis platform. This brings standardized and highly efficient reaction cascades thanks to stabilized enzymes. The reactions take place in water at ambient temperature and atmospheric pressure, using carbon sources that are renewable. No polluting by-product is generated. Type: | 0 | 0 | 0 | 10 |
 | Cilcare MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, … Type: | 43 | 12 | 39 | 43 |
 | Immusmol Immusmol develops small molecule antibodies for research, diagnostics and therapy. Combining 25 years of experience in antigen design, we offer to target low molecular weight molecules, which are not usually addressed by antibodies, such as amino acid metabolites, lipids, saccharids, toxins, pesticide residues, small molecule drugs, ... Compatible with existing antibody-based technologies, our small molecule antibodies can serve for: > VISUALIZATION: Small molecule antibodies currently represent the only applicable technology for the visualization of small molecules in cells and tissues by IF or IHC. > QUANTIFICATION: Combined with ELISA/EIA technologies, small molecule antibodies enable rapid and robust detection of small … Type: | 1 | 1 | 0 | 10 |
 | ENYO Pharma Developing therapeutics for diseases with impaired kidney function ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function. The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH). Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor. Type: | 11 | 6 | 6 | 34 |
 | easy2data, Email Lists & Lists of companies to download Type: | 0 | 0 | 0 | 1 |
 | MEXBRAIN [Automatic translation follows] Therapeutic dialysis devices for metal extraction MexBrain develops medical devices capable of extracting metals specifically, quickly and in a controlled manner. MexBrain has designed an ultrachelating platform: fluids capable of extracting metals associated with dialysis systems. These devices are specific to the targeted metals and have an adjustable extraction capacity. No medication or product circulates directly in the body, limiting side effects. Nanotechnologies, Dialysis, Metals, and Chelation Type: | 12 | 2 | 3 | 13 |
 | Dotter.science [Automatic translation follows] Manage your clinical studies with complete peace of mind thanks to our eCRF solution. 👉 https://www.dotter.science/ Dotter.science is an online platform that optimizes the design, entry (eCRF) and electronic management of clinical research protocols. Intended for researchers, healthcare institutions and organizations managing health research protocols, Dotter allows you to save time and gain traceability, while controlling your costs. On Dotter, each researcher has the possibility to manage and carry out their entire protocol on the platform, by minimizing the tedious aspects of clinical studies and securing processes. Clinical research, SaaS, Medical protocols, and Statistical analysis Type: | 3 | 2 | 1 | 2 |
 | Bio Logbook Precision Healthcare Technology - Innovative data science to detect early biological dysfunctions. Our mission is to enhance patient care through the use of AI and expert systems: Adapting expert systems of industrial excellence, unprecedented in the healthcare field Preventing diseases through early and automatic detection of biological imbalances Maintaining the population's health Bringing new analytical methods to biomedical research. Analyse statistique, Recherche développement en santé, IA en santé, and Système Expert en santé Type: | 12 | 3 | 5 | 10 |
 | SYNAXYS Accelerate drug development for neurological diseases SYNAXYS is French biotech specialized in the characterization of the response of the nervous system for nutraceutic, pharmaceutic and veterinary applications. We offer a complete range of R&D services to support drug development, from defining the dose effects in a human model, to identify biological targets and action mechanism, acute and chronic toxicity, or comparison to established treatments. Our field of application: - Drug positioning - Therapeutic evaluation in a diease model - Neuro-oncology - Data generation for IA modeling Neuro-engineering, Neuronal diseases modeling, Neuro-oncology, Autism, Alzheimer disease, and Glioblastoma Type: | 2 | 0 | 2 | 2 |
 | Next Neurotech Innovative neurosurgical technologies for epilepsy. NxNeuro is developing technologies to treat patients suffering from refractory epilepsy. These are epilepsies that cannot be treated by drugs, leaving 4,800,000 patients in a therapeutic impasse. Thanks to our patented technologies, we help healthcare professionals to better manage these patients suffering from severe epilepsies. 🏥 NxNeuro medical devices enable more effective diagnosis and treatment, offering the chance of a cure to as many people as possible. Our goals: to treat more, to treat better, to treat without waiting, to give disease no chance. 🧠⚕️ If you too would like to join us in the … Type: | 6 | 4 | 2 | 2 |
 | ODONTELLA [Automatic translation follows] The company has filed patents relating to the use of Odontella, the world's first marine microalgae authorized for human consumption. These patents concern the formulation, based on the marine microalgae Odontella, of a wide range of new agri-food products, healthy for the whole family. (Beverages, ready meals, etc.) The company is working on a new value chain, based on Odontella, by developing the first marine plant-based salmon that can directly replace the consumption of farmed salmon, in terms of taste, appearance, texture, nutritional quality and also price. This patented product developed in partnership with specialized laboratories is … Type: | 3 | 2 | 0 | 2 |
 | Care Factory [Automatic translation follows] Care Factory is a new, fast-growing consulting firm. We work with our clients (industrialists, public and private payers, healthcare institutions) on issues of innovation, market access, optimization of care pathways and patient support. Health, Care pathways, Patient programs, Market Access, Medico-economic studies, and Strategic partnerships Type: | 0 | 0 | 0 | 3 |
 | Bon Vivant Animal-free dairy proteins, for a sustainable future. We are a French biotechnology company developing cutting-edge precision fermentation techniques, dedicated to take part in the environmental transition within the dairy production sector. Our innovative technology enables the production of dairy proteins without the need for animals, significantly reducing the ecological footprint. By providing our clients with cutting-edge, sustainable ingredients, we empower them to create a diverse range of dairy products identical to those you already love, both environmentally conscious and nutritionally rich. Join us on our journey to shaping a future where ethical dairy alternatives are complementary to conventional farming and … Type: | 52 | 13 | 40 | 111 |
Startup